diclofenac has been researched along with Acquired Nephrogenic Diabetes Insipidus in 1 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lavrinenko, VA | 1 |
| Babina, AV | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium[NCT05188131] | Phase 4 | 12 participants (Actual) | Interventional | 2021-10-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for diclofenac and Acquired Nephrogenic Diabetes Insipidus
| Article | Year |
|---|---|
Efficiency of Osmotic Concentration after Combined Treatment with Vasopressin and Blockage of Prostaglandin Synthesis.
Topics: Animals; Antidiuretic Agents; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Diclofe | 2016 |